- Home
- STSS vs ALBT Comparison
STSS vs ALBT Comparison
Compare STSS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- ALBT
- Stock Information
- Founded
- STSS 2017
- ALBT 2014
- Country
- STSS United States
- ALBT United States
- Employees
- STSS N/A
- ALBT N/A
- Industry
- STSS Medical/Dental Instruments
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STSS Health Care
- ALBT Health Care
- Exchange
- STSS Nasdaq
- ALBT Nasdaq
- Market Cap
- STSS 4.6M
- ALBT 5.3M
- IPO Year
- STSS 2022
- ALBT N/A
- Fundamental
- Price
- STSS $5.87
- ALBT $3.41
- Analyst Decision
- STSS
- ALBT
- Analyst Count
- STSS 0
- ALBT 0
- Target Price
- STSS N/A
- ALBT N/A
- AVG Volume (30 Days)
- STSS 2.6M
- ALBT 12.4K
- Earning Date
- STSS 05-15-2025
- ALBT 05-13-2025
- Dividend Yield
- STSS N/A
- ALBT N/A
- EPS Growth
- STSS N/A
- ALBT N/A
- EPS
- STSS N/A
- ALBT N/A
- Revenue
- STSS N/A
- ALBT $807,235.00
- Revenue This Year
- STSS N/A
- ALBT N/A
- Revenue Next Year
- STSS N/A
- ALBT N/A
- P/E Ratio
- STSS N/A
- ALBT N/A
- Revenue Growth
- STSS N/A
- ALBT N/A
- 52 Week Low
- STSS $3.36
- ALBT $2.11
- 52 Week High
- STSS $2,904.00
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- STSS 42.25
- ALBT 37.21
- Support Level
- STSS $3.44
- ALBT $3.40
- Resistance Level
- STSS $7.04
- ALBT $3.79
- Average True Range (ATR)
- STSS 0.51
- ALBT 0.19
- MACD
- STSS 1.33
- ALBT -0.02
- Stochastic Oscillator
- STSS 67.47
- ALBT 1.83
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.